An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The proposed study is a 12-week, open-label pilot study of sublocade (extended-release burprenorphine, BXR) as treatment for opiate use disorder (OUD) testing positive for Highly Potent Synthetic Opioids (HPSO). The investigators plan to enroll 10 participants into the study.
Epistemonikos ID: d6be5caa05366a7b2dc1de56b681d7df4883a0ce
First added on: May 22, 2024